Date published: 2026-6-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

PHT-427 (CAS 1191951-57-1)

0.0(0)
Write a reviewAsk a question

Alternate Names:
4-dodecyl-N-(1,3,4-thiadiazol-2-yl)benzenesulfonamide
Application:
PHT-427 is a pleckstrin homology domain inhibitor to Akt and PKB Kinase (PDPK1)
CAS Number:
1191951-57-1
Purity:
≥98%
Molecular Weight:
409.61
Molecular Formula:
C20H31N3O2S2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

PHT-427 is a dual Akt and PKB Kinase (PDPK1) inhibitor (Ki values: Akt = 2.7 μM and PKB Kinase (PDPK1) = 5.2 μM). PHT-427 is a pleckstrin homology domain inhibitor to Akt/PKB Kinase (PDPK1). PHT-427 significantly reduces phosphorylation of phospho-Ser241-PKB Kinase (PDPK1) and phospho-Thr308-Akt in PC-3 prostate cancer cells which shows that PHT-427 could inhibit both Akt and PKB Kinase (PDPK1). PHT-427 also inhibits translocation of the Akt and PKB Kinase (PDPK1) PH domains in plasma membrane. PHT-427 induces apoptosis and inhibits Akt phosphorylation (IC50 = 6.3 μM), mainly on Akt Ser473 residue and less strongly on the Akt Thr308 residue without affecting total Akt protein expression. PHT-427 also shows antiproliferation in Panc-1 cells (IC50 = 65 μM).

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

PHT-427, 10 mg

sc-364582
10 mg
$68.00

PHT-427, 50 mg

sc-364582A
50 mg
$405.00